European Randomised Study of TOOKAD ® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up

Condition:   Cancer of the Prostate Intervention:   Other: no intervention (post study follow up) Sponsors:   Steba Biotech S.A.;   International Drug Development Institute;   ICON plc Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials